v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 25 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Operating activities:              
Net loss $ (1,643) $ (1,998) $ (2,892) $ (3,046) $ (3,641) $ (5,938)  
Adjustments to reconcile net loss to cash used in operating activities:              
Depreciation expense 0   1   1 2  
Stock-based compensation expense         64 261  
Change in operating lease right-of-use assets         27 23  
Change in operating assets and liabilities:              
Prepaid expenses and other current assets         (51) 133  
Accounts payable         (1,284) 371  
Accrued expenses         (220) 269  
Operating lease liabilities         (27) (23)  
Cash used in operating activities         (5,131) (4,902)  
Financing activities:              
Payment for fractional shares in connection with reverse stock split         (1) (1)  
Payment of stock issuance costs         (364) (944)  
Cash provided by financing activities         7,849 4,996  
Net increase in cash and cash equivalents         2,718 94  
Cash and cash equivalents at beginning of period   $ 8,229   $ 5,028 8,229 5,028  
Cash and cash equivalents at end of period 10,947   $ 5,122   10,947 5,122 $ 10,947
Supplemental disclosure of non-cash financing activities:              
Deferred stock issuance costs in accounts payable and accrued expenses         0 29  
Issuance of warrants for payment of stock issuance costs         0 123  
Through Financing Transactions              
Financing activities:              
Proceeds from issuance of common stock under ATM facility         0 5,000  
At The Market Offering              
Financing activities:              
Proceeds from issuance of common stock under ATM facility $ 1,395       $ 8,214 $ 941 $ 14,379